EUVIMEDEUVIMED entdecken
Crossref

Effects of SGLT2 Inhibitors and DPP-4 Inhibitors on Advanced Glycation End Products

Masataka Kusunoki, Fumiya Hisano, Shin-Ichi Matsuda, Akiko Kusunoki, Tomokazu Abe, Kazuhiko Tsutsumi, Tetsuro Miyata

Drug Research · 2024-02 · 74 (02) · 77-80

DOI: 10.1055/a-2234-1797 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, online erschienen am 29.01.2024. Verfasst von Masataka Kusunoki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Motor Function and Metabolism, Research Center of Health, Physical Fitness and Sports, Nagoya University, Nagoya City, Aichi,…. Hauptthemen laut MEDLINE: Dipeptidyl-Peptidase IV Inhibitors, Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Type 2, Cardiovascular Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical trials have revealed that sodium glucose cotransporter 2 (SGLT2) inhibitors suppress the onset of heart failure and cardiovascular death in diabetic patients. On the other hand, few reports have been published concerning such effects of dipeptidyl peptidase-4 (DPP-4) inhibitors. We undertook the present study to evaluate the effects of SGLT2 inhibitors and DPP-4 inhibitors on the advanced glycation end products (AGEs), well known as a risk factor for the development of cardiovascular disorders. Type 2 diabetes mellitus were divided into two groups and treated with either SGLT2 inhibitors or DPP-4 inhibitors for 3 months. Before and after the 3-month treatment period with each drug, the AGEs and diabetes-related parameters were measured. Methylglyoxal-derived hydroimidazolone-1 (MG-H1) was measured as one of the AGEs. In the SGLT2 inhibitor group, both the blood HbA1c and MG-H1 levels decreased significantly after the 3-month treatment period. In the DPP-4 inhibitor group, only the blood HbA1c level decreased significantly, with no significant change of the blood MG-H1 level. SGLT2 inhibitor reduced both the blood levels of HbA1c and AGEs (MG-H1). Considering that the blood levels of AGEs are associated with the risk of heart failure and cardiovascular disorders, the results of the present study suggest that the effect of SGLT2 inhibitors in suppressing cardiovascular death might be mediated by the reduction in the blood levels of AGEs induced by this class of drugs. DPP-4 inhibitors showed no significant effects on the blood levels of AGEs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dipeptidyl-Peptidase IV InhibitorsSodium-Glucose Transporter 2 InhibitorsDiabetes Mellitus, Type 2Cardiovascular DiseasesHeart FailureHumansGlycated HemoglobinHypoglycemic Agents

Substanzen

Dipeptidyl-Peptidase IV InhibitorsSodium-Glucose Transporter 2 InhibitorsGlycated HemoglobinHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Diabetes, Motor Function and Metabolism, Research Center of Health, Physical Fitness and Sports, Nagoya University, Nagoya City, Aichi, Japan.
  • Graduate School of Medicine, Department of Integrated Health Sciences, Nagoya University, Nagoya City, Aichi, Japan.
  • Department of Data Science, Faculty of Science and Technology, Nanzan University, Nagoya City, Aichi, Japan.
  • Akishima Clinic. Sakae, Naka-ku, Nagoya City, Japan.
  • Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
  • Office of Medical Education, School of Medicine, International University of Health and Welfare, Narita City, Chiba, Japan.

Zitieren

APA

Kusunoki, M., Hisano, F., Matsuda, S. I., Kusunoki, A., Abe, T., Tsutsumi, K., & Miyata, T. (2024). Effects of SGLT2 Inhibitors and DPP-4 Inhibitors on Advanced Glycation End Products. Drug Research, 74(02), 77-80. https://doi.org/10.1055/a-2234-1797

Vancouver

Kusunoki M, Hisano F, Matsuda SI, Kusunoki A, Abe T, Tsutsumi K, et al. Effects of SGLT2 Inhibitors and DPP-4 Inhibitors on Advanced Glycation End Products. Drug Research. 2024;74(02):77-80. doi:10.1055/a-2234-1797

BibTeX
@article{Kusunoki2024,
  author = {Kusunoki, Masataka and Hisano, Fumiya and Matsuda, Shin-Ichi and Kusunoki, Akiko and Abe, Tomokazu and Tsutsumi, Kazuhiko and Miyata, Tetsuro},
  title = {Effects of SGLT2 Inhibitors and DPP-4 Inhibitors on Advanced Glycation End Products},
  journal = {Drug Research},
  year = {2024},
  volume = {74},
  number = {02},
  pages = {77--80},
  doi = {10.1055/a-2234-1797}
}
Kostenlos starten →